<VariationArchive RecordType="classified" VariationID="1342123" VariationName="NM_002666.5(PLIN1):c.1308_1309del (p.Pro439fs)" VariationType="Deletion" Accession="VCV001342123" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-02-26" MostRecentSubmission="2022-02-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1333521" VariationID="1342123">
      <GeneList>
        <Gene Symbol="LOC130057886" FullName="ATAC-STARR-seq lymphoblastoid silent region 6802" GeneID="130057886" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="89665749" stop="89665858" display_start="89665749" display_stop="89665858" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PLIN1" FullName="perilipin 1" GeneID="5346" HGNC_ID="HGNC:9076" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="89664367" stop="89679367" display_start="89664367" display_stop="89679367" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="90207597" stop="90222647" display_start="90207597" display_stop="90222647" Strand="-" />
          </Location>
          <OMIM>170290</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002666.5(PLIN1):c.1308_1309del (p.Pro439fs)</Name>
      <CanonicalSPDI>NC_000015.10:89665842:CA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="89665843" stop="89665844" display_start="89665843" display_stop="89665844" variantLength="2" positionVCF="89665842" referenceAlleleVCF="CCA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="90209074" stop="90209075" display_start="90209074" display_stop="90209075" variantLength="2" positionVCF="90209073" referenceAlleleVCF="CCA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P439fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.89665843_89665844del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.89665843_89665844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.90209074_90209075del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.90209074_90209075del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029172.1" sequenceAccession="NG_029172" sequenceVersion="1" change="g.18574_18575del">
            <Expression>NG_029172.1:g.18574_18575del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145311.2" sequenceAccession="NM_001145311" sequenceVersion="2" change="c.1308_1309del">
            <Expression>NM_001145311.2:c.1308_1309del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138783.1" sequenceAccession="NP_001138783" sequenceVersion="1" change="p.Pro439fs">
            <Expression>NP_001138783.1:p.Pro439fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002666.5" sequenceAccession="NM_002666" sequenceVersion="5" change="c.1308_1309del" MANESelect="true">
            <Expression>NM_002666.5:c.1308_1309del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002657.3" sequenceAccession="NP_002657" sequenceVersion="3" change="p.Pro439fs">
            <Expression>NP_002657.3:p.Pro439fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="170290.0003" DB="OMIM" />
        <XRef Type="rs" ID="2141523598" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002666.5(PLIN1):c.1308_1309del (p.Pro439fs) AND PLIN1-related familial partial lipodystrophy" Accession="RCV001837713" Version="1">
        <ClassifiedConditionList TraitSetID="7494">
          <ClassifiedCondition DB="MedGen" ID="C5191005">PLIN1-related familial partial lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-02-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-02-26" MostRecentSubmission="2022-02-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25114292</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7494" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16066" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PLIN1-related familial partial lipodystrophy</ElementValue>
                <XRef ID="MONDO:0013478" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS</ElementValue>
                <XRef Type="MIM" ID="613877" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial partial lipodystrophy 4</ElementValue>
                <XRef ID="Lipodystrophy%2C+familial+partial%2C+type+4/8760" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPLD4</ElementValue>
                <XRef Type="MIM" ID="613877" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12601" />
                <XRef ID="12601" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="280356" DB="Orphanet" />
              <XRef ID="C5191005" DB="MedGen" />
              <XRef ID="MONDO:0013478" DB="MONDO" />
              <XRef Type="MIM" ID="613877" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4103110" SubmissionDate="2022-02-21" DateLastUpdated="2022-02-26" DateCreated="2022-02-26">
        <ClinVarSubmissionID localKey="170290.0003_LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4" title="PLIN1, 2-BP DEL, 1298TG_LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4" />
        <ClinVarAccession Accession="SCV002098315" DateUpdated="2022-02-26" DateCreated="2022-02-26" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 6 patients from 2 unrelated families with autosomal dominant partial lipodystrophy type 4 (FPLD4; 613877), Kozusko et al. (2015) identified a heterozygous 2-bp deletion (c.1298delTG) in exon 9 of the PLIN1 gene, resulting in a translational frameshift and the incorporation of 125 aberrant amino acids from residue 439 onward (439fs), producing an elongated protein of 563 amino acids. The mutation segregated with the disorder in both families. Adipose tissue derived from 1 patient showed decreased levels of PLIN1 compared to controls. In vitro expression studies in preadipocytes indicated that the mutant protein is likely degraded by the proteasome. Expression of the mutant protein resulted in smaller lipid droplets and inefficient inhibition of basal lipolysis despite retention of its ability to bind ABHD5 (604780). Levels of PLIN2 (103195) were increased. The authors hypothesized that the reduced expression of the protein was a major factor in the pathogenesis. The patients had partial lipodystrophy, severe insulin resistance, severe dyslipidemia, and nonalcoholic fatty liver disease. Gestational hypertension was present in affected women.</Attribute>
              <Citation>
                <ID Source="PubMed">25114292</ID>
              </Citation>
              <XRef DB="OMIM" ID="613877" Type="MIM" />
              <XRef DB="OMIM" ID="604780" Type="MIM" />
              <XRef DB="OMIM" ID="103195" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLIN1" />
          </GeneList>
          <Name>PLIN1, 2-BP DEL, 1298TG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1298TG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="170290.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4103110" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4" MappingRef="Preferred">
        <MedGen CUI="C5191005" Name="PLIN1-related familial partial lipodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

